Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: OHSU Knight Cancer Institute
Condition: Atrial Fibrillation, Esophageal Carcinoma
NCT06067438
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.